Joanna Q. Hudson

1.9k total citations
60 papers, 897 citations indexed

About

Joanna Q. Hudson is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Joanna Q. Hudson has authored 60 papers receiving a total of 897 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Nephrology, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Pharmacology. Recurrent topics in Joanna Q. Hudson's work include Dialysis and Renal Disease Management (10 papers), Potassium and Related Disorders (9 papers) and Chronic Kidney Disease and Diabetes (8 papers). Joanna Q. Hudson is often cited by papers focused on Dialysis and Renal Disease Management (10 papers), Potassium and Related Disorders (9 papers) and Chronic Kidney Disease and Diabetes (8 papers). Joanna Q. Hudson collaborates with scholars based in United States, Canada and Tanzania. Joanna Q. Hudson's co-authors include Thomas D. Nolin, Timothy M. Griffin, Wendy L. St. Peter, Melanie S. Joy, Joyce E. Broyles, Thomas C. Dowling, Christopher K. Finch, Thomas J. Comstock, Michael Kinter and Yao Fu and has published in prestigious journals such as SHILAP Revista de lepidopterología, The FASEB Journal and Environmental Health Perspectives.

In The Last Decade

Joanna Q. Hudson

55 papers receiving 870 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joanna Q. Hudson United States 18 218 154 151 132 106 60 897
Chaker Ben Salem Tunisia 13 158 0.7× 98 0.6× 93 0.6× 127 1.0× 139 1.3× 71 839
Savaş Öztürk Türkiye 18 224 1.0× 53 0.3× 93 0.6× 112 0.8× 187 1.8× 144 1.1k
Richard A. Petruschke United States 17 190 0.9× 191 1.2× 150 1.0× 72 0.5× 275 2.6× 31 1.9k
Gordon Choi Hong Kong 18 242 1.1× 494 3.2× 53 0.4× 274 2.1× 130 1.2× 31 1.2k
Houssem Hmouda Tunisia 10 144 0.7× 52 0.3× 54 0.4× 70 0.5× 95 0.9× 20 593
Hong Cheng China 19 344 1.6× 45 0.3× 40 0.3× 117 0.9× 189 1.8× 95 990
William M. Bennett United States 18 244 1.1× 182 1.2× 73 0.5× 172 1.3× 238 2.2× 23 1.6k
Arnošt Martínek Czechia 15 174 0.8× 88 0.6× 36 0.2× 188 1.4× 185 1.7× 56 942
Mark A. Klausner United States 14 446 2.0× 26 0.2× 110 0.7× 191 1.4× 118 1.1× 24 1.2k
Duane G. Wombolt United States 15 302 1.4× 142 0.9× 61 0.4× 60 0.5× 85 0.8× 36 1.1k

Countries citing papers authored by Joanna Q. Hudson

Since Specialization
Citations

This map shows the geographic impact of Joanna Q. Hudson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanna Q. Hudson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanna Q. Hudson more than expected).

Fields of papers citing papers by Joanna Q. Hudson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanna Q. Hudson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanna Q. Hudson. The network helps show where Joanna Q. Hudson may publish in the future.

Co-authorship network of co-authors of Joanna Q. Hudson

This figure shows the co-authorship network connecting the top 25 collaborators of Joanna Q. Hudson. A scholar is included among the top collaborators of Joanna Q. Hudson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanna Q. Hudson. Joanna Q. Hudson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hall, Elizabeth A., et al.. (2025). TikTok as a tool for learning top 300 drugs. American Journal of Pharmaceutical Education. 89(6). 101419–101419.
3.
Swanson, Joseph M., et al.. (2024). Validation of Two Scoring Tools to Predict Risk of Augmented Renal Clearance in Trauma Patients. Journal of Surgical Research. 300. 526–533.
4.
Rafique, Zubaid, et al.. (2021). Hyperkalemia management in the emergency department: An expert panel consensus. SHILAP Revista de lepidopterología. 2(5). e12572–e12572. 23 indexed citations
5.
Meaney, Calvin J., Harold J. Manley, Amy Barton Pai, et al.. (2020). Nephrology practice and research network opinion paper: Pharmacists' perspectives on the Advancing American Kidney Health initiative. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 3(7). 1355–1368. 7 indexed citations
6.
Hastings, Margaret, et al.. (2020). Predictors of Hypophosphatemia and Outcomes during Continuous Renal Replacement Therapy. Blood Purification. 49(6). 700–707. 17 indexed citations
7.
Canada, Robert B., et al.. (2020). Levetiracetam pharmacokinetics in critically ill patients undergoing renal replacement therapy. Journal of Critical Care. 61. 216–220. 7 indexed citations
8.
Hudson, Joanna Q. & Thomas D. Nolin. (2018). Pragmatic Use of Kidney Function Estimates for Drug Dosing: The Tide Is Turning. Advances in Chronic Kidney Disease. 25(1). 14–20. 36 indexed citations
9.
Hudson, Joanna Q., et al.. (2018). Inadequate antibiotic dosing in patients receiving sustained low efficiency dialysis. International Journal of Clinical Pharmacy. 40(5). 1250–1256. 14 indexed citations
10.
Hudson, Joanna Q., et al.. (2017). Exercise induces transient inflammatory and pro-fibrotic remodeling of the infrapatellar fat pad. Osteoarthritis and Cartilage. 25. S67–S67. 1 indexed citations
11.
Hudson, Joanna Q., et al.. (2014). Effect ofα-Lipoic Acid on Oxidative Stress in End-Stage Renal Disease Patients Receiving Intravenous Iron. PubMed. 2014. 1–7. 6 indexed citations
12.
Hudson, Joanna Q., Yusuke Kawashima, Naoka Komori, et al.. (2014). Metabolic enrichment of omega-3 polyunsaturated fatty acids does not reduce the onset of idiopathic knee osteoarthritis in mice. Osteoarthritis and Cartilage. 22(9). 1301–1309. 33 indexed citations
13.
Canada, Robert B., et al.. (2012). Evaluation of Vancomycin and Gentamicin Dialysis Clearance Using In Vivo and In Vitro Systems. Renal Failure. 34(6). 703–707. 9 indexed citations
14.
Hudson, Joanna Q., Darius Mason, & K. Huch. (2010). Estimates of Kidney Function in Obese African Americans with Chronic Kidney Disease. Nephron Clinical Practice. 118(2). c101–c108. 5 indexed citations
15.
Hudson, Joanna Q., et al.. (2009). Hyperkalemia‐Induced Paralysis. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 29(10). 1270–1272. 7 indexed citations
16.
Redmond, Amy M., et al.. (2005). Use of Famotidine in Adult Patients with End-Stage Renal Disease: Assessment of Dosing and Mental Status Changes. The American Journal of the Medical Sciences. 330(1). 8–10. 7 indexed citations
17.
Zillich, Alan J., Joseph J. Saseen, Darren W. Grabe, et al.. (2004). Caring for Patients with Chronic Kidney Disease: A Joint Opinion of the Ambulatory Care and the Nephrology Practice and Research Networks of the American College of Clinical Pharmacy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 25(1). 123–143. 24 indexed citations
18.
Hudson, Joanna Q. & Kristine S. Schonder. (2002). Advances in Anemia Management in Chronic Kidney Disease. Journal of Pharmacy Practice. 15(6). 437–455.
19.
Forman, Joel, Jacqueline Moline, Elsa Cernichiari, et al.. (2000). A cluster of pediatric metallic mercury exposure cases treated with meso-2,3-dimercaptosuccinic acid (DMSA). Environmental Health Perspectives. 108(6). 575–577. 48 indexed citations
20.
Hudson, Joanna Q., Ralph E. Small, & Lenore M. Buckley. (1998). Perceptions of Pharmacists about Adverse Effects of Corticosteroid Therapy: Focus on Osteoporosis. Journal of the American Pharmaceutical Association (1996). 38(6). 710–716. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chaker Ben Salem Breakdown of academic impact, for papers by Savaş Öztürk Breakdown of academic impact, for papers by Richard A. Petruschke Breakdown of academic impact, for papers by Gordon Choi Breakdown of academic impact, for papers by Houssem Hmouda Breakdown of academic impact, for papers by Hong Cheng Breakdown of academic impact, for papers by William M. Bennett Breakdown of academic impact, for papers by Arnošt Martínek Breakdown of academic impact, for papers by Mark A. Klausner Breakdown of academic impact, for papers by Duane G. Wombolt
Rankless by CCL
2026